localized transitional cell cancer of the renal pelvis and ureter
Showing 9951 - 9975 of >10,000
Gastro-esophageal Cancer Trial (Resistance training, Protein supplement)
Not yet recruiting
- Gastro-esophageal Cancer
- Resistance training
- Protein supplement
- (no location specified)
Dec 15, 2022
Hearing Loss, Head Neck Cancer Trial run by the National Institute on Deafness and Other Communication Disorders (NIDCD)
Not yet recruiting
- Hearing Loss
- Head and Neck Cancer
- Atorvastatin
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Olaparib Real-world Utilization and Clinical Outcomes in France,
Active, not recruiting
- Ovary Cancer
-
Saint Pierre, La Réunion (oversea France), France
- +51 more
Jan 23, 2023
Lung Cancer Trial in Singapore (Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays)
Recruiting
- Lung Cancer
- Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays
-
Singapore, Singapore
- +2 more
Feb 1, 2023
Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)
Active, not recruiting
- Malignant Neoplasms of Female Genital Organs
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
CESM ABMR Breast Cancer Screening Trial
Completed
- Breast Cancer Screening
- Contrast-enhanced Spectral Mammography (CESM)
-
Seattle, WashingtonSeattle Cancer Care Alliance
Jan 4, 2023
Value of Ultra-fast Prostate MRI in Prostate Cancer
Not yet recruiting
- Prostate Cancer
- Prostate MRI
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich
Jun 11, 2023
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
Recruiting
- Breast Cancer
- Magnetic Resonance Imaging Simulation
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 5, 2023
gastRic Cancer patIentS Undergoing Multimodal trEatment
Recruiting
- Gastric Cancer
- +3 more
- Observational Survey
-
Lublin, PolandMedical University of Lublin
Feb 9, 2023
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +2 more
- Questionnaire Administration
- Tonation Breathing Technique
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
COVID-19, End Stage Renal Disease Trial in Copenhagen, Herlev, Hillerød (Hydroxychloroquine)
Withdrawn
- COVID-19
- End Stage Renal Disease
-
Copenhagen, Denmark
- +2 more
Nov 5, 2021
Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)
Recruiting
- Cancer of the Head and Neck
- +3 more
- Cisplatin injection
-
Columbia, MissouriUniversity of Missouri
Oct 31, 2022
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Dasatinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 15, 2021
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Norris ORIEN Total Cancer Care
Recruiting
- Cancer Risk
- Malignant Neoplasm
- Biospecimen Collection
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 19, 2022
The RISC Registry--Risk Informed Screening Registry
Not yet recruiting
- Breast Cancer Risk
- Cancer Risk Screening and Follow up
-
Palo Alto, CaliforniaPHEI--Precision Health Equity Initiative
Apr 28, 2023
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
- etoposide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 19, 2022
CDH1 Germline Mutations in Lobular Breast Cancer
Active, not recruiting
- Lobular Breast Carcinoma
- CDH1 Gene Inactivation
-
Milan, ItalyEuropean Institute of Oncology
Jan 11, 2022
Leukemia Trial (Prehabilitation)
Not yet recruiting
- Leukemia
- Prehabilitation
- (no location specified)
Dec 5, 2022
Colorectal Surgery, Geriatric Assessment, Quality of Life Trial in Brussels, Jette (Geriatric Assessment)
Recruiting
- Colorectal Surgery
- +2 more
- Geriatric Assessment
-
Brussels, Belgium
- +1 more
Apr 28, 2023
NSCLC/Oligometastatic Cancer (Single Lung Lesion) Trial in Dublin (Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR))
Recruiting
- NSCLC/Oligometastatic Cancer (Single Lung Lesion)
- Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)
-
Dublin, Ireland
- +1 more
Feb 11, 2022
Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)
Withdrawn
- Leukemia
- Stem Cell Transplantation
-
Munich, Bavaria, Germany3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022